| |
| | Cancerquest: Current Research on Angiogenesis Inhibitors: MMP Inhibitors |
 | | Cianfrocca M, Cooley TP, Lee JY, Rudek MA, Scadden DT, Ratner L, Pluda JM, Figg WD, Krown SE, Dezube BJ. |
 | | Beliveau R, Gingras D, Kruger EA, Lamy S, Sirois P, Simard B, Sirois MG, Tranqui L, Baffert F, Beaulieu E, Dimitriadou V, Pepin MC, Courjal F, Ricard I, Poyet P, Falardeau P, Figg WD, Dupont E. "The antiangiogenic agent neovastat (AE-941) inhibits vascular endothelial growth factor-mediated biological effects." Clin Cancer Res (2002). |
 | | Batist G, Patenaude F, Champagne P, Croteau D, Levinton C, Hariton C, Escudier B, Dupont E. "Neovastat (AE-941) in refractory renal cell carcinoma patients: report of a phase II trial with two dose levels." Ann Oncol (2002). |
| www.cancerquest.org /printfriendly.cfm?printpage=1207 (393 words) |
|